Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Transcriptional and post-transcriptional regulation of human Treg identity and function

Award Number: R01AI189605
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/06/2026
PERIOD OF PERFORMANCE END DATE: 01/31/2030

Group Awards By:

View Award Description

Transcriptional and post-transcriptional regulation of human Treg identity and function - ABSTRACT Regulatory T cells (Tregs) are essential for maintaining immune homeostasis by preventing excessive inflammation and autoimmune disease. Treg stability is governed by the lineage-defining transcription factor FOXP3. However, exposure to chronic inflammation or repeated T cell receptor stimulation can cause Tregs to destabilize, resulting in loss of FOXP3 expression and suppressive function. The gene regulatory networks controlling Treg identity and function remain incompletely understood, especially in human T cells. To address this, we conducted CRISPR nuclease screening for trans-regulatory factors that control the maintenance and suppression of FOXP3 expression in human Tregs. Our screen highlighted SATB1, SRF, IRF4, and YBX1 as top regulators for further investigation. This proposal aims to define the multi-level regulatory networks governing Treg stability. Aim 1 focuses on the transcriptional regulation of FOXP3 by elucidating how key transcription factors (TFs) modulate FOXP3 expression and Treg stability. We will define the functional roles of key TFs by mapping their binding sites and assessing their effects on chromatin accessibility. We will employ base editing of key cis-regulatory elements (CREs) that modulate FOXP3 expression to identify critical DNA regions and provide a high-resolution map of TF-CRE interactions in Tregs. Aim 2 investigates post- transcriptional regulation of FOXP3, focusing on YBX1, an RNA-binding protein we identified as a novel regulator of FOXP3 expression. Our preliminary data indicate that YBX1 knockout in human Tregs enhances FOXP3 levels and prevents Treg destabilization under inflammatory conditions. We have also uncovered YBX1-bound transcripts as well as identified pathways regulated by YBX1. We will further characterize broad cellular pathways regulated by YBX1 and assess direct FOXP3 regulation by systematic mutagenesis of YBX1 binding targets in key Treg transcripts. We will perform in vitro and in vivo functional assessments in both aims to test the impacts of modulating key regulatory elements and their targets on Treg lineage stability and function. Together, these studies will provide a comprehensive map of FOXP3 regulation at transcriptional and post-transcriptional levels, and identify strategies to modulate key elements to enhance Treg suppressive function and resistance to destabilization. Our findings will provide fundamental insights into Treg biology and inform the development of more effective Treg-based immunotherapies for autoimmune diseases, transplantation, and inflammatory disorders.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $3,601,712 )
2026	2026	J.DAVID GLADSTONE INSTITUTES	1650 OWENS ST	SAN FRANCISCO	CA	94158	SAN FRANCISCO	USA	Allergy and Infectious Diseases Research	000	1	2/6/2026	NEW	$3,601,712
														Subtotal = $3,601,712

Grand Total All Awards = $3,601,712

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Transcriptional and post-transcriptional regulation of human Treg identity and function

Award Number: R01AI189605

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/06/2026

PERIOD OF PERFORMANCE END DATE: 01/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer